Targeted delivery of a ligand–drug conjugate via formyl peptide receptor 1 through cholesterol-dependent endocytosis

J Wang, M Chen, S Li, RD Ye - Molecular Pharmaceutics, 2019 - ACS Publications
G protein-coupled receptors (GPCRs) undergo ligand-induced internalization that carries
the cognate ligands into intracellular compartments. The present study explores this property …

[HTML][HTML] In Silico Conformation of the Drug Colchicine into Tubulin Models and Acute Phytotoxic Activity on Cucumis sativus Radicles

OA Peña-Morán, J Jiménez-Pérez, L Cerón-Romero… - Plants, 2022 - mdpi.com
Many tests are used to determine the toxic activity of miscellaneous substances, and those
that are simple, fast, and inexpensive are useful for screening compounds with applications …

Structural Perspective of Benzophenones Targeting Tubulin as Anticancer Agents

P Chourasia, V Asati, S Agarwal… - Mini Reviews in …, 2023 - ingentaconnect.com
Cancer is the leading cause of death and the most significant determinant of life expectancy
in almost every country in this twenty-first century. According to the World Health …

Combretastatin A4-loaded Poly (Lactic-co-glycolic Acid)/Soybean Lecithin Nanoparticles with Enhanced Drug Dissolution Rate and Antiproliferation Activity

Y Cao, AMQ Ahmed, HH Du, W Sun, X Lu… - Current Drug …, 2022 - ingentaconnect.com
Objective: This study aimed to prepare combretastatin A4 (CA4)-loaded nanoparticles (CA4
NPs) using poly (lactic-co-glycolic acid)(PLGA) and soybean lecithin (Lipoid S100) as …

Chemical Biology Studies on Aplyronine A, A PPI-Inducing Antitumor Macrolide from Sea Hare

M Kita - New Tide of Natural Product Chemistry, 2023 - Springer
The antitumor macrolide aplyronine A (ApA) disturbs microtubule (MT) dynamics by inducing
the protein–protein interaction (PPI) between actin and tubulin. However, the detailed …

Cell-derived nanoplatforms for cancer therapy

PMP Lins - 2021 - teses.usp.br
Nanomaterials are promising platforms for cancer therapy due to their innate passive
targeting. The success of nanomaterials into the clinics depends on their blood circulation …

[HTML][HTML] STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models

G Rozic, L Paukov, Z Cohen, I Shapira, A Duek… - Oncotarget, 2018 - ncbi.nlm.nih.gov
STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in
vivo multiple myeloma models - PMC Back to Top Skip to main content NIH NLM Logo Access …

The current perspectives of nanoparticles in cellular and organ-specific drug targeting in biological system

A Muthuraman - Nanostructures for the engineering of cells, tissues and …, 2018 - Elsevier
The current perspectives on the nanoparticle have proved that it plays a promising role in
the field of nanomedicine. The basic understanding of nanoparticle action in the biological …

Développement d'anticorps mono ou bi-conjugués innovants pour le ciblage des cancers du sein triple négatifs

J Most - 2023 - theses.hal.science
Les cancers du sein triple négatifs, un sous-type de cancer du sein présentant un déficit de
trois récepteurs communément utilisés en thérapie, représentent un important défi …

Planejamento in silico de cumarinas como possíveis inibidores da Cinesina Eg5

JPS Souza - 2021 - lume.ufrgs.br
O câncer de pulmão é uma das maiores causas de morte no mundo, sendo responsável por
aproximadamente 2, 1 milhões de novos casos ao ano. No Brasil, é o quarto tipo de câncer …